Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

24-hour IV lidocaine to reduce lung complications after emergency abdominal surgery for infection

Official title: The Effect of Continuous Intravenous Infusion of Lidocaine on Postoperative Pulmonary Complications and Prognosis in Emergency Surgical Patients With Intra-abdominal Infection

Run by Shanghai Zhongshan Hospital · NCT06304779 · Data updated 2026-11-12

This will try a 24-hour continuous intravenous lidocaine infusion to see if it lowers postoperative lung complications in adults having emergency laparotomy for intra-abdominal infection.

More Postoperative Complications trials

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment428 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedOctober 31, 2023
Main results expectedSeptember 30, 2027
Study endsNovember 30, 2027
Registry record updatedApril 29, 2026
Trial IDNCT06304779 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing emergency surgery for suspected gastrointestinal perforation or obstruction with signs of infection and planned general anesthesia who can give informed consent are the ideal candidates.

Probably not a fit

Patients with local anesthetic allergy, pregnancy, ongoing renal replacement therapy, significant arrhythmias or heart failure, very low platelet counts, need for immediate secondary surgery for anastomotic leak, or recent participation in other trials are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing emergency laparotomy for intra-abdominal infection receive either a continuous 24-hour intravenous infusion of lidocaine or a placebo during general anesthesia. The primary outcome is incidence of postoperative pulmonary complications within two days, including unplanned ventilation, acute respiratory distress syndrome, or postoperative pneumonia. Secondary outcomes include the proportion requiring mechanical ventilation, perioperative organ function, length of hospital stay, and 30-day postoperative outcomes. Standard infection markers and surgical exclusion criteria are used to screen participants.

Why it matters

Potential benefit: If effective, this approach could reduce postoperative pulmonary complications, decrease ventilator use, shorten hospital stays, and improve 30-day outcomes.

How similar studies have gone: Prior randomized trials of perioperative systemic lidocaine have shown benefits for pain, opioid use, and recovery after elective abdominal surgery, but applying continuous IV lidocaine specifically to prevent early postoperative pulmonary complications in emergency intra-abdominal infection is relatively novel and not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years, any gender.
* Patients suspected of digestive tract perforation or obstruction based on physical examination, confirmed by imaging, requiring emergency surgical treatment.
* The anesthesia method is general anesthesia
* I or the patient's family have carefully read and signed the informed consent form
* Serum procalcitonin (PCT) at inflammatory levels or leukocytosis (\>12×109/L) or leukopenia (\<4×109/L) or \>10% naive leukocytes

Exclusion Criteria:

* Have a history of local anesthesia drug allergy
* Pregnant patients
* Patients receiving renal replacement therapy
* Patients with arrhythmias or heart failure (second or third-degree atrioventricular block or left ventricular ejection fraction(LVEF)
* Preoperative platelet count\<80 × 109/L
* Patients who require secondary surgery for postoperative anastomotic fistula
* Patients who have participated in other clinical studies

Where it's running

  • Zhongshan Hospital,Fudan university
    Shanghai, Shanghai Municipality, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.